Public Outreach

School and Lab Visits

The NCCR RNA & Disease offers to schools the possibility of a school visit, during which the topic of RNA & Disease will be presented to the students by a NCCR member. Alternatively, NCCR labs can be visited by school classes.

If you are interested in these possibilities, please contact us: office[at]

Nacht der Forschung 2017

The NCCR RNA & Disease conveyed its scientific activities to the public by participating at the "Nacht der Forschung" on September 16th, 2017.

A "Parcours" through the central Dogma - from DNA to RNA to Proteins - and beyond:

At the "Nacht der Forschung" guests could explore the world of RNA by visiting the interactive NCCR RNA & Disease "Parcours". Besides a number of posters and videos illustrating our research, the visitors had the unique opportunity to directly learn from our scientists and to carry out experiments on-site. The Bernese NCCR groups of Rory Johnson, Oliver Mühlemann, Mariusz Nowacki, Norbert Polacek, Marc -David Ruepp, and André Schneider represented the NCCR RNA & Disease with over 50 researchers.

Link to Nacht der Forschung Webpage

Scientifica 2017

This year's edition of the Scientifica - Zurich Science Days, was running under the theme big data and attracted over 30'000 visitors. The NCCR RNA & Disease was present with a booth, at which visitors were taken on a journey to learn about miRNAs, the role of big data for their study and the therapeutic potential of small RNAs.  The NCCR groups of Constance Ciaudo, Helge Grosshans, Jonathan Hall, Markus Stoffel and Mihaela Zavolan contributed to the 2017 participation.

Scientifica 2015

At the Scientifica – Zurich Science Days this year’s topic was "light" and the fair was visited by 25'000 persons. The NCCR RNA & Disease presented a project on developing treatments for the genetic disease Erythropoietic Protoporphyria (EPP). Patients suffering from EPP are very photosensitive such that even short exposures to daylight lead to extremely painful skin reactions. The project aims to develop therapies based on alternative splicing modulation. This project is a collaboration between the NCCR groups of Jonathan Hall and Daniel Schümperli and the associated Porphyria group headed by Elisabeth Minder, Xiaoye Schneider and Jasmin Barman.